Guaraldi G.; Meschiari M.; Cozzi-Lepri A.; Milic J.; Tonelli R.; Menozzi M.; Franceschini E.; Cuomo G.; Orlando G.; Borghi V.; Santoro A.; Di Gaetano M.; Puzzolante C.; Carli F.; Bedini A.; Corradi L.; Fantini R.; Castaniere I.; Tabbi L.; Girardis M.; Tedeschi S.; Giannella M.; Bartoletti M.; Pascale R.; Dolci G.; Brugioni L.; Pietrangelo A.; Cossarizza A.; Pea F.; Clini E.; Salvarani C.; Massari M.; Viale P.L.; Mussini C., Tocilizumab in patients with severe COVID-19: a retrospective cohort study, «THE LANCET. RHEUMATOLOGY», 2020, 2, pp. e474 - e484 [articolo]
Vanino E.; Tadolini M.; Attard L.; Cascavilla A.; Pea F.; Viale P., A multidrug resistant tuberculosis case treated with continuous infusion of meropenem in outpatient care, «INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE», 2019, 23, pp. 1042 - 1043 [replica/breve intervento]
Giacobbe D.R.; De Rosa F.G.; Del Bono V.; Grossi P.A.; Pea F.; Petrosillo N.; Rossolini G.M.; Tascini C.; Tumbarello M.; Viale P.; Bassetti M., Ceftobiprole: drug evaluation and place in therapy, «EXPERT REVIEW OF ANTI-INFECTIVE THERAPY», 2019, 17, pp. 689 - 698 [articolo]Open Access
Pea F.; Krause R.; Muller C.; Hennart B.; Richardson M.; Meinitzer A.; Wiesen M.H.J.; Wiktorowicz T.; Spickermann J.; Henriksen A.S., Interlaboratory Analysis of Isavuconazole Plasma Concentration Assays among European Laboratories, «THERAPEUTIC DRUG MONITORING», 2019, 41, pp. 657 - 664 [articolo]
Cojutti, Pier Giorgio; Maximova, Natalia; Schillani, Giulia; Hope, William; Pea, Federico, Population pharmacokinetics of continuous-infusion ceftazidime in febrile neutropenic children undergoing HSCT: implications for target attainment for empirical treatment against Pseudomonas aeruginosa, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2019, 74, pp. 1648 - 1655 [articolo]
Cojutti P.G.; Merelli M.; Bassetti M.; Pea F., Proactive therapeutic drug monitoring (TDM) may be helpful in managing long-term treatment with linezolid safely: Findings from a monocentric, prospective, open-label, interventional study, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2019, 74, pp. 3588 - 3595 [articolo]
Crass R.L.; Cojutti P.G.; Pai M.P.; Pea F., Reappraisal of linezolid dosing in renal impairment to improve safety, «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2019, 63, pp. 1 - 9 [articolo]
Cojutti P.G.; Merelli M.; Allegri L.; Damante G.; Bassetti M.; Pea F., Successful and safe long-term treatment of cerebral aspergillosis with high-dose voriconazole guided by therapeutic drug monitoring, «BRITISH JOURNAL OF CLINICAL PHARMACOLOGY», 2019, 85, pp. 266 - 269 [articolo]
Righi, Elda; Carnelutti, Alessia; Baccarani, Umberto; Sartor, Assunta; Cojutti, Piergiorgio; Bassetti, Matteo; Pea, Federico, Treatment of Candida Infections with Fluconazole in Adult Liver Transplant Recipients: Is TDM-guided Dosing Adaptation Helpful?, «TRANSPLANT INFECTIOUS DISEASE», 2019, 21, pp. e13113 - - [articolo]
Pascale R.; Giannella M.; Bartoletti M.; Viale P.; Pea F., Use of meropenem in treating carbapenem-resistant Enterobacteriaceae infections, «EXPERT REVIEW OF ANTI-INFECTIVE THERAPY», 2019, 17, pp. 819 - 827 [articolo]
Posteraro B.; Pea F.; Masucci L.; Posteraro P.; Sanguinetti M., Actoxumab + bezlotoxumab combination: what promise for Clostridium difficile treatment?, «EXPERT OPINION ON BIOLOGICAL THERAPY», 2018, 18, pp. 469 - 476 [articolo]
Righi E.; Muser D.; Carnelutti A.; Pea F.; Sartor A.; Bassetti M., Candida endocarditis and the impact of antifungal treatment on the corrected QT interval: a case report, «DRUGS & THERAPY PERSPECTIVES», 2018, 34, pp. 402 - 403 [articolo]
Peghin M.; Maiani M.; Castaldo N.; Givone F.; Righi E.; Lechiancole A.; Sartor A.; Pea F.; Livi U.; Bassetti M., Ceftolozane/tazobactam for the treatment of MDR Pseudomonas aeruginosa left ventricular assist device infection as a bridge to heart transplant, «INFECTION», 2018, 46, pp. 263 - 265 [replica/breve intervento]
Cojutti P.G.; Candoni A.; Lazzarotto D.; Rabassi N.; Fanin R.; Hope W.; Pea F., Co-administration of proton pump inhibitors and/or of steroids may be a risk factor for low trough concentrations of posaconazole delayed-released tablets in adult patients with haematological malignancies, «BRITISH JOURNAL OF CLINICAL PHARMACOLOGY», 2018, 84, pp. 2544 - 2550 [articolo]
Cojutti P.G.; Merelli M.; De Stefanis P.; Fregonese C.; Lucchese F.; Bassetti M.; Pea F., Disposition of ceftobiprole during continuous venous-venous hemodiafiltration (CVVHDF) in a single critically ill patient, «EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY», 2018, 74, pp. 1671 - 1672 [replica/breve intervento]
